Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function-Reference-Cited by-同舟云学术

Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function

Published:2012-07-13 Issue:1 Volume:27 Page:170-182
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

DiLillo D J,Weinberg J B,Yoshizaki A,Horikawa M,Bryant J M,Iwata Y,Matsushita T,Matta K M,Chen Y,Venturi G M,Russo G,Gockerman J P,Moore J O,Diehl L F,Volkheimer A D,Friedman D R,Lanasa M C,Hall R P,Tedder T F

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2012165.pdf

Reference51 articles.

1. Chiorazzi N, Rai KR, Ferrarini M . Chronic lymphocytic leukemia. N Engl J Med 2005; 352: 804–815.

2. Damle RN, Ghiotto F, Valetto A, Albesiano E, Fais F, Yan XJ et al. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood 2002; 99: 4087–4093.

3. Nordgren TM, Joshi SS . The etiology of chronic lymphocytic leukemia: another look at the relationship between B1 cells and CLL. Open Leuk J 2010; 3: 69–73.

4. Chiorazzi N, Ferrarini M . Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. Blood 2011; 117: 1781–1791.

5. Gorgun G, Holderried TA, Zahrieh D, Neuberg D, Gribben JG . Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells. J Clin Invest 2005; 115: 1797–1805.

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tuning the B-CLL microenvironment: evidence for BAG3 protein- mediated regulation of stromal fibroblasts activity;Cell Death Discovery;2024-08-28

2. Features of the T-cell immune response in patients with hematological diseases after SARS-CoV-2 infection and vaccination;Russian journal of hematology and transfusiology;2024-08-18

3. Evaluation of infectious morbidity due to BTK inhibitors in indolent B-cell lymphomas: latest research findings and systematic analysis;Expert Opinion on Pharmacotherapy;2024-07-23

4. The complexities of T-cell dysfunction in chronic lymphocytic leukemia;Seminars in Hematology;2024-06

5. Revolutionizing tumor immunotherapy: unleashing the power of progenitor exhausted T cells;Cancer Biology & Medicine;2024-05-31